VAS
LLY icon

Vestmark Advisory Solutions’s Eli Lilly LLY Stock Holding History

Vestmark Advisory Solutions’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.7M Buy
53,968
+2,425
+5% +$2.48M 0.61% 26
2026
Q1 		$47.4M Buy
51,543
+17,781
+53% +$18M 0.53% 35
2025
Q4 		$36.3M Buy
33,762
+16,217
+92% +$15.5M 0.49% 35
2025
Q3 		$13.4M Buy
17,545
+4,400
+33% +$3.27M 0.26% 89
2025
Q2 		$10.2M Sell
13,145
-10,557
-45% -$8.2M 0.15% 115
2025
Q1 		$19.6M Buy
23,702
+11,591
+96% +$9.64M 0.5% 39
2024
Q4 		$9.35M Buy
12,111
+1,332
+12% +$1.1M 0.32% 64
2024
Q3 		$9.55M Buy
10,779
+692
+7% +$622K 0.36% 57
2024
Q2 		$9.13M Sell
10,087
-811
-7% -$649K 0.38% 55
2024
Q1 		$8.48M Sell
10,898
-310
-3% -$221K 0.37% 61
2023
Q4 		$6.53M Sell
11,208
-475
-4% -$277K 0.33% 70
2023
Q3 		$6.28M Sell
11,683
-8,588
-42% -$4.43M 0.46% 42
2023
Q2 		$9.51M Buy
20,271
+971
+5% +$407K 0.36% 61
2023
Q1 		$6.63M Buy
19,300
+2,181
+13% +$736K 0.29% 87
2022
Q4 		$6.26M Buy
17,119
+534
+3% +$189K 0.31% 65
2022
Q3 		$5.36M Sell
16,585
-107
-0.6% -$33.9K 0.3% 76
2022
Q2 		$5.41M Buy
16,692
+3,988
+31% +$1.2M 0.31% 71
2022
Q1 		$3.64M Buy
12,704
+547
+4% +$141K 0.21% 111
2021
Q4 		$3.36M Buy
12,157
+364
+3% +$92.3K 0.19% 121
2021
Q3 		$2.73M Buy
11,793
+1,869
+19% +$461K 0.18% 136
2021
Q2 		$2.28M Buy
9,924
+592
+6% +$119K 0.16% 158
2021
Q1 		$1.74M Buy
9,332
+585
+7% +$114K 0.15% 185
2020
Q4 		$1.48M Buy
8,747
+489
+6% +$73K 0.17% 171
2020
Q3 		$1.22M Sell
8,258
-1,541
-16% -$238K 0.16% 179
2020
Q2 		$1.61M Buy
9,799
+127
+1% +$19.5K 0.25% 122
2020
Q1 		$1.34M Sell
9,672
-729
-7% -$100K 0.26% 113
2019
Q4 		$1.37M Sell
10,401
-1,521
-13% -$176K 0.28% 129
2019
Q3 		$1.33M Buy
11,922
+2,216
+23% +$247K 0.22% 146
2019
Q2 		$1.07M Sell
9,706
-1,434
-13% -$169K 0.18% 166
2019
Q1 		$1.45M Buy
+11,140
New +$1.35M 0.26% 119

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vestmark Advisory Solutions's LLY Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Eli Lilly (LLY) stake by 4.7% in Q2 2026, buying an estimated $2.48M and bringing the position to 53,968 shares worth $64.7M. The position accounts for 0.61% of the portfolio, ranked #26.

Vestmark Advisory Solutions first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vestmark Advisory Solutions held 53,968 shares of Eli Lilly worth $64.7M as of Q2 2026.
  • Vestmark Advisory Solutions bought 2,425 Eli Lilly shares in Q2 2026, an estimated $2.48M.
  • Eli Lilly made up 0.61% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #26 holding.
  • Vestmark Advisory Solutions first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.